Jade Biosciences, Inc. (JBIO) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -24.08M | -33.65M | -22.12M | -36.53M | -11.05M | 37.3M | -20.43M | -23.67M | -14.8M | -15.61M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | - | -204.6% | -159.31% | -78.8% | 25.36% | 338.96% | - | - | - | - |
| Net Income | -40.37M | -31.93M | -25.18M | -32.13M | -5.43M | -16.28M | -24.77M | -23.19M | -20.41M | -19.56M |
| Depreciation & Amortization | 9K | 0 | 12K | 1K | 8K | 0 | 28K | 28K | 28K | 25K |
| Stock-Based Compensation | 0 | 0 | 4.29M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 6.94M | 8.82M | -191K | -8.63M | 943.22K | 42.43M | 3.17M | 3.44M | 2.31M | 2.43M |
| Working Capital Changes | 9.34M | -10.54M | -1.06M | 4.23M | -6.57M | 11.15M | 1.14M | -3.96M | 3.27M | 1.5M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 2.33M | 301K | -4.88M | 5.09M | -684K | -1.49M | 948K | 835K | -1.04M | -2.01M |
| Cash from Investing | -8.47M | -98.16M | -148.71M | -12.99M | 13.13M | -26.83M | 18M | 8.83M | 5.65M | -13.13M |
| Capital Expenditures | 0 | -3K | -57K | -136K | 0 | 0 | 0 | 0 | -64K | -32K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -98.16M | -59K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | -795K | 170.16M | 0 | 190.61M | 554K | 69.92M | 24.38M | 471K | 463K | 20K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 95M | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 45K | 170.16M | 0 | 190.45M | 554K | -25.08M | 24.38M | 471K | 463K | 20K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -840K | 0 | 0 | 156K | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -33.35M | -50.11M | -170.84M | 176.72M | 2.64M | 46K | 21.95M | -14.37M | -8.69M | -28.72M |
| Free Cash Flow | -24.08M | -33.65M | -22.18M | -36.67M | -11.05M | 37.3M | -20.43M | -23.67M | -14.86M | -15.64M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | - | -204.63% | -159.46% | -79.47% | 25.68% | 338.47% | - | - | - | - |
| FCF per Share | -0.42 | -0.68 | -0.56 | -1.29 | -13.34 | 11.82 | -24.87 | -29.81 | -18.78 | -19.81 |
| FCF Conversion (FCF/Net Income) | 0.60x | 1.05x | 0.88x | 1.14x | 2.03x | -2.29x | 0.82x | 1.02x | 0.73x | 0.80x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |